0.9(top 50%)
impact factor
137(top 100%)
papers
142(top 50%)
citations
5(top 50%)
h-index
0.9(top 50%)
extended IF
158
all documents
172
doc citations
9(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI studyAtherosclerosis Plus202117
2High-density lipoprotein cholesterol: A marker of COVID-19 infection severity?Atherosclerosis Plus202115
3Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic conditionAtherosclerosis Plus20219
4Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI studyAtherosclerosis Plus20228
5High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasoundAtherosclerosis Plus20216
6Colchicine reduces atherosclerotic plaque vulnerability in rabbitsAtherosclerosis Plus20216
7Clinical characteristics and cardiovascular outcomes among young patients with acute myocardial infarction in Kerala, India: A secondary analysis of ACS QUIK trialAtherosclerosis Plus20226
8Association between Helicobacter pylori infection and carotid atherosclerosis in Chinese adultsAtherosclerosis Plus20215
9Utilization of IVUS improves all-cause mortality in patients undergoing invasive coronary angiographyAtherosclerosis Plus20215
10Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profileAtherosclerosis Plus20215
11Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-upAtherosclerosis Plus20235
12Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular diseaseAtherosclerosis Plus20224
13Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemiaAtherosclerosis Plus20224
14Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levelsAtherosclerosis Plus20224
15Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 diseaseAtherosclerosis Plus20234
16Assessment of plasma ceramides as predictor for subclinical atherosclerosisAtherosclerosis Plus20213
17Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative reviewAtherosclerosis Plus20213
18Tamoxifen-independent Cre-activity in SMMHC-CreER miceAtherosclerosis Plus20223
19Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytesAtherosclerosis Plus20223
20Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progressionAtherosclerosis Plus20233
21SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular diseaseAtherosclerosis Plus20233
22Impact of atherosclerotic extent on clinical outcome for diabetic patients with non-obstructive coronary artery diseaseAtherosclerosis Plus20212
23Differential association of flow velocities in the carotid artery with plaques, intima media thickness and cardiac functionAtherosclerosis Plus20212
24Age dependent association between remnant cholesterol and cardiovascular diseaseAtherosclerosis Plus20212
25Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I studyAtherosclerosis Plus20212
26Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetesAtherosclerosis Plus20212
27Hypoglycemia-induced changes in complement pathways in type 2 diabetesAtherosclerosis Plus20212
28Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancyAtherosclerosis Plus20222
29Urine ketone bodies and adverse outcomes in patients with acute ischemic stroke or TIAAtherosclerosis Plus20222
30The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgeryAtherosclerosis Plus20222
31Lipids, lipoproteins and prevalence of familial hypercholesterolemia in the Faroe Islands – Results from a nationwide laboratory databaseAtherosclerosis Plus20222
32Circular RNA expression profile of H2O2 induced ferroptosis model of human coronary artery endothelial cellsAtherosclerosis Plus20222
33The circulating furin-cleaved/mature PCSK9 ratio has a potential prognostic significance in statin-naïve patients with acute ST elevation myocardial infarctionAtherosclerosis Plus20222
34Periostin contributes to the adventitial remodeling of atherosclerosis by activating adventitial fibroblastsAtherosclerosis Plus20222
35Dyslipidemia and the preventive potential in the Greenlandic populationAtherosclerosis Plus20232
36HDL and chronic kidney diseaseAtherosclerosis Plus20232
37The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarctionAtherosclerosis Plus20232
38Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?Atherosclerosis Plus20232
39The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndromeAtherosclerosis Plus20232
40Smad2 inhibition of MET transcription potentiates human vascular smooth muscle cell apoptosisAtherosclerosis Plus20211
41Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosisAtherosclerosis Plus20211
42The West Midland Familial Hypercholesterolaemia (FH) screening programme: Evaluating the utility of the 12 SNP polygenic risk score (PRS) across ethnic groupingsAtherosclerosis Plus20211
43Association of remnant cholesterol with intra- and extra-cranial atherosclerosis in Chinese community populationAtherosclerosis Plus20211
44Identification of the atherosclerosis phenotype in vivo by vascular duplex ultrasonography in ApoE-deficient dogsAtherosclerosis Plus20221
45Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic eventsAtherosclerosis Plus20221
46Secular trends in serum lipid profiles in young adults in Norway, 2001-19Atherosclerosis Plus20221
47A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patientsAtherosclerosis Plus20221
48Semaglutide treatment attenuates vessel remodelling in ApoE−/− mice following vascular injury and blood flow perturbationAtherosclerosis Plus20221
49Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular eventsAtherosclerosis Plus20221
50Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohortAtherosclerosis Plus20221